cid,cmpdname,cmpdsynonym,mw,mf,polararea,complexity,xlogp,heavycnt,hbonddonor,hbondacc,rotbonds,inchi,isosmiles,canonicalsmiles,inchikey,iupacname,exactmass,monoisotopicmass,charge,covalentunitcnt,isotopeatomcnt,totalatomstereocnt,definedatomstereocnt,undefinedatomstereocnt,totalbondstereocnt,definedbondstereocnt,undefinedbondstereocnt,pclidcnt,gpidcnt,gpfamilycnt,neighbortype,meshheadings,annothits,annothitcnt,aids,cidcdate,sidsrcname,depcatg,annotation
69761759,CDK5 inhibitor 20-223,CDK5 inhibitor 20-223|865317-30-2|SCHEMBL6385683|CHEMBL4553956|AGVIDDQHAQSPIZ-UHFFFAOYSA-N|AKOS040755438|MS-24416|HY-123772|CS-0085638|N-(5-cyclobutyl-1H-pyrazol-3-yl)-2-naphthalen-2-ylacetamide|N-(5-Cyclobutyl-2H-pyrazol-3-yl)-2-naphthalene-2-yl-acetamide,305.400,C19H19N3O,57.800,423.000,3.700,23,2,2,4,"InChI=1S/C19H19N3O/c23-19(20-18-12-17(21-22-18)15-6-3-7-15)11-13-8-9-14-4-1-2-5-16(14)10-13/h1-2,4-5,8-10,12,15H,3,6-7,11H2,(H2,20,21,22,23)",C1CC(C1)C2=CC(=NN2)NC(=O)CC3=CC4=CC=CC=C4C=C3,C1CC(C1)C2=CC(=NN2)NC(=O)CC3=CC4=CC=CC=C4C=C3,AGVIDDQHAQSPIZ-UHFFFAOYSA-N,N-(5-cyclobutyl-1H-pyrazol-3-yl)-2-naphthalen-2-ylacetamide,305.153,305.153,0,1,0,0,0,0,0,0,0,1,1,1,2D+3D,NULL,Biological Test Results|Classification|Literature|Patents,4,1530064|1530065|1530066|1530067|1530068|1530069|1530070|1530071,20121201,AbaChemScene|AKos Consulting & Solutions|BenchChem|ChEMBL|DC Chemicals|Google Patents|IBM|Key Organics/BIONET|MedChemexpress MCE|MolPort|NextMove Software|PATENTSCOPE (WIPO)|Probes & Drugs portal|Starshine Chemical|SureChEMBL,Chemical Vendors|Curation Efforts|Governmental Organizations|Research and Development,NULL
138454872,[pThr3]-CDK5 Substrate,[pThr3]-CDK5 Substrate|HY-P1906|CS-0097996,1218.400,C53H100N15O15P,499.000,2160.000,-8.200,84,17,21,43,"InChI=1S/C53H100N15O15P/c1-32(2)31-41(53(78)79)66-49(74)38(19-7-12-26-56)64-47(72)37(18-6-11-25-55)61-44(69)33(3)60-46(71)36(17-5-10-24-54)63-48(73)39(20-8-13-27-57)65-51(76)42-23-16-30-68(42)52(77)43(34(4)83-84(80,81)82)67-50(75)40(21-9-14-28-58)62-45(70)35-22-15-29-59-35/h32-43,59H,5-31,54-58H2,1-4H3,(H,60,71)(H,61,69)(H,62,70)(H,63,73)(H,64,72)(H,65,76)(H,66,74)(H,67,75)(H,78,79)(H2,80,81,82)/t33-,34+,35-,36-,37-,38-,39-,40-,41-,42-,43-/m0/s1",C[C@H]([C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]2CCCN2)OP(=O)(O)O,CC(C)CC(C(=O)O)NC(=O)C(CCCCN)NC(=O)C(CCCCN)NC(=O)C(C)NC(=O)C(CCCCN)NC(=O)C(CCCCN)NC(=O)C1CCCN1C(=O)C(C(C)OP(=O)(O)O)NC(=O)C(CCCCN)NC(=O)C2CCCN2,DOSIYTHCWIDLCR-BJSZDZKQSA-N,"(2S)-2-[[(2S)-6-amino-2-[[(2S)-6-amino-2-[[(2S)-2-[[(2S)-6-amino-2-[[(2S)-6-amino-2-[[(2S)-1-[(2S,3R)-2-[[(2S)-6-amino-2-[[(2S)-pyrrolidine-2-carbonyl]amino]hexanoyl]amino]-3-phosphonooxybutanoyl]pyrrolidine-2-carbonyl]amino]hexanoyl]amino]hexanoyl]amino]propanoyl]amino]hexanoyl]amino]hexanoyl]amino]-4-methylpentanoic acid",1217.73,1217.73,0,1,0,11,11,0,0,0,0,0,0,0,2D,NULL,NULL,0,NULL,20190715,AbaChemScene|BOC Sciences|MedChemexpress MCE,Chemical Vendors,NULL
139291241,[pThr3]-CDK5 Substrate (TFA),[pThr3]-CDK5 Substrate (TFA)|HY-P1906A|CS-0103536,1332.500,C55H101F3N15O17P,537.000,2250.000,NULL,91,18,26,43,"InChI=1S/C53H100N15O15P.C2HF3O2/c1-32(2)31-41(53(78)79)66-49(74)38(19-7-12-26-56)64-47(72)37(18-6-11-25-55)61-44(69)33(3)60-46(71)36(17-5-10-24-54)63-48(73)39(20-8-13-27-57)65-51(76)42-23-16-30-68(42)52(77)43(34(4)83-84(80,81)82)67-50(75)40(21-9-14-28-58)62-45(70)35-22-15-29-59-35;3-2(4,5)1(6)7/h32-43,59H,5-31,54-58H2,1-4H3,(H,60,71)(H,61,69)(H,62,70)(H,63,73)(H,64,72)(H,65,76)(H,66,74)(H,67,75)(H,78,79)(H2,80,81,82);(H,6,7)/t33-,34+,35-,36-,37-,38-,39-,40-,41-,42-,43-;/m0./s1",C[C@H]([C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]2CCCN2)OP(=O)(O)O.C(=O)(C(F)(F)F)O,CC(C)CC(C(=O)O)NC(=O)C(CCCCN)NC(=O)C(CCCCN)NC(=O)C(C)NC(=O)C(CCCCN)NC(=O)C(CCCCN)NC(=O)C1CCCN1C(=O)C(C(C)OP(=O)(O)O)NC(=O)C(CCCCN)NC(=O)C2CCCN2.C(=O)(C(F)(F)F)O,QKAZHXZKNMQUIG-ZCKAZPTLSA-N,"(2S)-2-[[(2S)-6-amino-2-[[(2S)-6-amino-2-[[(2S)-2-[[(2S)-6-amino-2-[[(2S)-6-amino-2-[[(2S)-1-[(2S,3R)-2-[[(2S)-6-amino-2-[[(2S)-pyrrolidine-2-carbonyl]amino]hexanoyl]amino]-3-phosphonooxybutanoyl]pyrrolidine-2-carbonyl]amino]hexanoyl]amino]hexanoyl]amino]propanoyl]amino]hexanoyl]amino]hexanoyl]amino]-4-methylpentanoic acid;2,2,2-trifluoroacetic acid",1331.72,1331.72,0,2,0,11,11,0,0,0,0,0,0,0,2D,NULL,Classification,1,NULL,20191031,AbaChemScene|MedChemexpress MCE,Chemical Vendors,NULL
163196445,Cdk5-IN-2,CDK5-IN-2|CHEMBL5075328|EX-A6047|BDBM50585763|HY-145693|CS-0379374|2639542-22-4,481.600,C29H28FN5O,85.100,781.000,4.600,36,2,7,5,"InChI=1S/C29H28FN5O/c1-29(36,23-10-12-35(2)13-11-23)27-9-7-22-18-32-28(16-26(22)33-27)34-25-8-6-21(15-24(25)30)20-5-3-4-19(14-20)17-31/h3-9,14-16,18,23,36H,10-13H2,1-2H3,(H,32,34)/t29-/m1/s1",C[C@@](C1CCN(CC1)C)(C2=NC3=CC(=NC=C3C=C2)NC4=C(C=C(C=C4)C5=CC=CC(=C5)C#N)F)O,CC(C1CCN(CC1)C)(C2=NC3=CC(=NC=C3C=C2)NC4=C(C=C(C=C4)C5=CC=CC(=C5)C#N)F)O,KKNXJZMTIWJEEF-GDLZYMKVSA-N,"3-[3-fluoro-4-[[2-[(1R)-1-hydroxy-1-(1-methylpiperidin-4-yl)ethyl]-1,6-naphthyridin-7-yl]amino]phenyl]benzonitrile",481.228,481.228,0,1,0,1,1,0,0,0,0,1,0,0,2D,NULL,Biological Test Results|Classification|Literature,3,1825848|1825849|1825850,20220428,AbaChemScene|BindingDB|ChEMBL|Excenen Pharmatech|MedChemexpress MCE,Chemical Vendors|Curation Efforts|Research and Development,NULL
163323749,Cdk5-IN-1,CDK5-IN-1|AKOS040757921|CS-0254276|2639540-19-3,496.600,C24H25FN6O3S,122.000,808.000,2.400,35,2,9,6,"InChI=1S/C24H25FN6O3S/c1-30-9-7-19(8-10-30)35(33,34)24-5-2-16-14-26-23(13-22(16)28-24)27-21-4-3-18(12-20(21)25)31-11-6-17(15-32)29-31/h2-6,11-14,19,32H,7-10,15H2,1H3,(H,26,27)",CN1CCC(CC1)S(=O)(=O)C2=NC3=CC(=NC=C3C=C2)NC4=C(C=C(C=C4)N5C=CC(=N5)CO)F,CN1CCC(CC1)S(=O)(=O)C2=NC3=CC(=NC=C3C=C2)NC4=C(C=C(C=C4)N5C=CC(=N5)CO)F,IKQUPLXGMFFIRS-UHFFFAOYSA-N,"[1-[3-fluoro-4-[[2-(1-methylpiperidin-4-yl)sulfonyl-1,6-naphthyridin-7-yl]amino]phenyl]pyrazol-3-yl]methanol",496.169,496.169,0,1,0,0,0,0,0,0,0,0,0,0,2D,NULL,Classification,1,NULL,20220607,AbaChemScene|AKos Consulting & Solutions,Chemical Vendors,NULL
10155554,Gsk-3/cdk5/cdk2-IN-1,"GSK-3/CDK5/CDK2-IN-1|395074-72-3|SCHEMBL5998410|SCHEMBL5998411|EX-A5616|AKOS040754696|MS-25758|HY-134622|CS-0146132|N-(1-((1s,3s)-3-acetamidocyclobutyl)-1H-imidazol-4-yl)-2-(naphthalen-2-yl)acetamide",362.400,C21H22N4O2,76.000,548.000,2.200,27,2,3,5,"InChI=1S/C21H22N4O2/c1-14(26)23-18-10-19(11-18)25-12-20(22-13-25)24-21(27)9-15-6-7-16-4-2-3-5-17(16)8-15/h2-8,12-13,18-19H,9-11H2,1H3,(H,23,26)(H,24,27)",CC(=O)NC1CC(C1)N2C=C(N=C2)NC(=O)CC3=CC4=CC=CC=C4C=C3,CC(=O)NC1CC(C1)N2C=C(N=C2)NC(=O)CC3=CC4=CC=CC=C4C=C3,XJRCZTVFSOVAQW-UHFFFAOYSA-N,N-[1-(3-acetamidocyclobutyl)imidazol-4-yl]-2-naphthalen-2-ylacetamide,362.174,362.174,0,1,0,0,0,0,0,0,0,0,17,3,2D+3D,NULL,Patents,1,NULL,20061025,A2B Chem|AA BLOCKS|AbaChemScene|AKos Consulting & Solutions|ChemShuttle|ChemSpider|DC Chemicals|DiscoveryGate|eNovation Chemicals|Excenen Pharmatech|Google Patents|IBM|Key Organics/BIONET|MedChemexpress MCE|MolPort|NextBio|PATENTSCOPE (WIPO)|Probes & Drugs portal|SureChEMBL|Thomson Pharma,Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,NULL
156212722,Cdk5-IN-3,CDK5-IN-3|CHEMBL5081712|2639542-32-6|SCHEMBL23165993|EX-A6352|BDBM50585759|MS-25765|HY-145694|CS-0379377,362.500,C22H26N4O,61.300,475.000,3.200,27,2,5,4,"InChI=1S/C22H26N4O/c1-22(27,17-10-12-26(2)13-11-17)20-9-8-16-15-23-21(14-19(16)25-20)24-18-6-4-3-5-7-18/h3-9,14-15,17,27H,10-13H2,1-2H3,(H,23,24)/t22-/m1/s1",C[C@@](C1CCN(CC1)C)(C2=NC3=CC(=NC=C3C=C2)NC4=CC=CC=C4)O,CC(C1CCN(CC1)C)(C2=NC3=CC(=NC=C3C=C2)NC4=CC=CC=C4)O,MLZPRAPIZUZUNO-JOCHJYFZSA-N,"(1R)-1-(7-anilino-1,6-naphthyridin-2-yl)-1-(1-methylpiperidin-4-yl)ethanol",362.211,362.211,0,1,0,1,1,0,0,0,0,1,2,1,2D,NULL,Biological Test Results|Classification|Literature|Patents,4,1825848|1825849|1825850,20210821,AbaChemScene|BindingDB|ChEMBL|Excenen Pharmatech|Google Patents|Key Organics/BIONET|MedChemexpress MCE|PATENTSCOPE (WIPO)|Probes & Drugs portal|SureChEMBL,Chemical Vendors|Curation Efforts|Governmental Organizations|Research and Development,NULL
101937498,Pktpkkakkl,"PKTPKKAKKL|164669-07-2|(2S)-2-[[(2S)-6-amino-2-[[(2S)-6-amino-2-[[(2S)-2-[[(2S)-6-amino-2-[[(2S)-6-amino-2-[[(2S)-1-[(2S,3R)-2-[[(2S)-6-amino-2-[[(2S)-pyrrolidine-2-carbonyl]amino]hexanoyl]amino]-3-hydroxybutanoyl]pyrrolidine-2-carbonyl]amino]hexanoyl]amino]hexanoyl]amino]propanoyl]amino]hexanoyl]amino]hexanoyl]amino]-4-methylpentanoic acid|Cdk5 substrate|Histone H1(9-18)|AKOS040755680",1138.400,C53H99N15O12,453.000,1970.000,-4.800,80,16,18,41,"InChI=1S/C53H99N15O12/c1-32(2)31-41(53(79)80)66-49(75)38(19-7-12-26-56)64-47(73)37(18-6-11-25-55)61-44(70)33(3)60-46(72)36(17-5-10-24-54)63-48(74)39(20-8-13-27-57)65-51(77)42-23-16-30-68(42)52(78)43(34(4)69)67-50(76)40(21-9-14-28-58)62-45(71)35-22-15-29-59-35/h32-43,59,69H,5-31,54-58H2,1-4H3,(H,60,72)(H,61,70)(H,62,71)(H,63,74)(H,64,73)(H,65,77)(H,66,75)(H,67,76)(H,79,80)/t33-,34+,35-,36-,37-,38-,39-,40-,41-,42-,43-/m0/s1",C[C@H]([C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]2CCCN2)O,CC(C)CC(C(=O)O)NC(=O)C(CCCCN)NC(=O)C(CCCCN)NC(=O)C(C)NC(=O)C(CCCCN)NC(=O)C(CCCCN)NC(=O)C1CCCN1C(=O)C(C(C)O)NC(=O)C(CCCCN)NC(=O)C2CCCN2,ZSZMVAFYNVHXHA-BJSZDZKQSA-N,"(2S)-2-[[(2S)-6-amino-2-[[(2S)-6-amino-2-[[(2S)-2-[[(2S)-6-amino-2-[[(2S)-6-amino-2-[[(2S)-1-[(2S,3R)-2-[[(2S)-6-amino-2-[[(2S)-pyrrolidine-2-carbonyl]amino]hexanoyl]amino]-3-hydroxybutanoyl]pyrrolidine-2-carbonyl]amino]hexanoyl]amino]hexanoyl]amino]propanoyl]amino]hexanoyl]amino]hexanoyl]amino]-4-methylpentanoic acid",1137.76,1137.76,0,1,0,11,11,0,0,0,0,0,0,0,2D,NULL,Literature,1,NULL,20151218,"A2B Chem|AA BLOCKS|AKos Consulting & Solutions|BenchChem|J&H Chemical Co.,ltd|Japan Chemical Substance Dictionary (Nikkaji)|MolPort|Probes & Drugs portal|RR Scientific|Smolecule",Chemical Vendors|Governmental Organizations|Research and Development,NULL
168013018,H-Pro-Lys-Thr-Pro-Lys-Lys-Ala-Lys-Lys-Leu-OH.CH3CO2H,Cdk5 Substrate acetate|AKOS040755681,1198.500,C55H103N15O14,490.000,2000.000,NULL,84,17,20,41,"InChI=1S/C53H99N15O12.C2H4O2/c1-32(2)31-41(53(79)80)66-49(75)38(19-7-12-26-56)64-47(73)37(18-6-11-25-55)61-44(70)33(3)60-46(72)36(17-5-10-24-54)63-48(74)39(20-8-13-27-57)65-51(77)42-23-16-30-68(42)52(78)43(34(4)69)67-50(76)40(21-9-14-28-58)62-45(71)35-22-15-29-59-35;1-2(3)4/h32-43,59,69H,5-31,54-58H2,1-4H3,(H,60,72)(H,61,70)(H,62,71)(H,63,74)(H,64,73)(H,65,77)(H,66,75)(H,67,76)(H,79,80);1H3,(H,3,4)/t33-,34+,35-,36-,37-,38-,39-,40-,41-,42-,43-;/m0./s1",C[C@H]([C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]2CCCN2)O.CC(=O)O,CC(C)CC(C(=O)O)NC(=O)C(CCCCN)NC(=O)C(CCCCN)NC(=O)C(C)NC(=O)C(CCCCN)NC(=O)C(CCCCN)NC(=O)C1CCCN1C(=O)C(C(C)O)NC(=O)C(CCCCN)NC(=O)C2CCCN2.CC(=O)O,XPRIYFHLXPQREY-ZCKAZPTLSA-N,"acetic acid;(2S)-2-[[(2S)-6-amino-2-[[(2S)-6-amino-2-[[(2S)-2-[[(2S)-6-amino-2-[[(2S)-6-amino-2-[[(2S)-1-[(2S,3R)-2-[[(2S)-6-amino-2-[[(2S)-pyrrolidine-2-carbonyl]amino]hexanoyl]amino]-3-hydroxybutanoyl]pyrrolidine-2-carbonyl]amino]hexanoyl]amino]hexanoyl]amino]propanoyl]amino]hexanoyl]amino]hexanoyl]amino]-4-methylpentanoic acid",1197.78,1197.78,0,2,0,11,11,0,0,0,0,0,0,0,2D,NULL,NULL,0,NULL,20230517,AKos Consulting & Solutions,Chemical Vendors,NULL
